Inari Medical Inc
(NARI)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 41,208 | 70,192 | 67,207 | 39,208 | 89,182 |
| Marketable Securities | 70,397 | 39,547 | 34,595 | 76,855 | 262,113 |
| Receivables | 84,403 | 81,631 | 78,621 | 70,119 | 69,595 |
| Inventories | 55,210 | 49,359 | 44,650 | 42,900 | 40,227 |
| TOTAL | $263,386 | $249,352 | $233,313 | $235,563 | $469,061 |
| Non-Current Assets | |||||
| PPE Net | 24,098 | 23,005 | 20,761 | 20,929 | 21,243 |
| Investments And Advances | 4,301 | 4,242 | 4,676 | 4,117 | 9,466 |
| Intangibles | 357,153 | 347,507 | 355,416 | 365,219 | 0 |
| Other Non-Current Assets | 48,301 | 48,824 | 47,610 | 48,407 | 49,065 |
| TOTAL | $433,853 | $423,578 | $428,463 | $438,672 | $79,774 |
| Total Assets | $697,239 | $672,930 | $661,776 | $674,235 | $548,835 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 15,523 | 16,375 | 12,026 | 10,577 | 10,091 |
| Accrued Expenses | 76,881 | 65,605 | 33,544 | 15,364 | 13,040 |
| Other current liabilities | 54,797 | 54,363 | 38,748 | 48,706 | 41,305 |
| TOTAL | $148,780 | $138,261 | $86,037 | $76,339 | $66,066 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 76,950 | 75,734 | 93,114 | 96,755 | 30,627 |
| TOTAL | $113,698 | $110,860 | $128,509 | $132,986 | $30,627 |
| Total Liabilities | $262,478 | $249,121 | $214,546 | $209,325 | $96,693 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 58,544 | 58,267 | 58,138 | 57,961 | 57,590 |
| Common Shares | 58 | 58 | 58 | 58 | 58 |
| Retained earnings | -122,403 | -104,036 | -72,688 | -48,486 | -43,821 |
| Other shareholders' equity | 13,145 | -837 | 1,522 | 8,885 | -1,158 |
| TOTAL | $434,761 | $423,809 | $447,230 | $464,910 | $452,142 |
| Total Liabilities And Equity | $697,239 | $672,930 | $661,776 | $674,235 | $548,835 |